Ngā hua rapu - Bruce Robinson

Whakamahine hua
  1. 1
    Benign asbestos pleural effusion: diagnosis and course.

    Benign asbestos pleural effusion: diagnosis and course. mā Bruce Robinson, Arthur W. Musk

    I whakaputaina 1981
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Natural killer cells are present in the normal human lung but are functionally impotent.

    Natural killer cells are present in the normal human lung but are functionally impotent. mā Bruce Robinson, P Pinkston, Ronald G. Crystal

    I whakaputaina 1984
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment

    The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment mā Delia J. Nelson, Scott Fisher, Bruce Robinson

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Risk of ESRD in the United States

    Risk of ESRD in the United States mā Patrick Albertus, Hal Morgenstern, Bruce Robinson, Rajiv Saran

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.

    Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. mā Bruce Robinson, Theodore L. McLemore, Ronald G. Crystal

    I whakaputaina 1985
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Authors’ Reply

    Authors’ Reply mā Murilo Guedes, Bruce Robinson, Brian Bieber, Roberto Pecoits–Filho

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all

    Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all mā Robbert van der Most, Andrew Currie, Bruce Robinson, Richard Lake

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Dialysis Outcomes and Practice Patterns Study (DOPPS)

    Dialysis Outcomes and Practice Patterns Study (DOPPS) mā Bruce Robinson, Brian Bieber, Ronald L. Pisoni, Friedrich K. Port

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    The DOPPS Practice Monitor for US Dialysis Care: Trends Through December 2011

    The DOPPS Practice Monitor for US Dialysis Care: Trends Through December 2011 mā Douglas S. Fuller, Ronald L. Pisoni, Brian Bieber, Brenda W. Gillespie, Bruce Robinson

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.

    Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis. mā A Venet, A J Hance, Cesare Saltini, Bruce Robinson, Ronald G. Crystal

    I whakaputaina 1985
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Programmed Death Ligand 2 in Cancer-Induced Immune Suppression

    Programmed Death Ligand 2 in Cancer-Induced Immune Suppression mā Esdy Rozali, Stanleyson V. Hato, Bruce Robinson, Richard Lake, W. Joost Lesterhuis

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Projecting ESRD Incidence and Prevalence in the United States through 2030

    Projecting ESRD Incidence and Prevalence in the United States through 2030 mā Keith McCullough, Hal Morgenstern, Rajiv Saran, William H. Herman, Bruce Robinson

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    The DOPPS Practice Monitor for US Dialysis Care: Trends Through August 2011

    The DOPPS Practice Monitor for US Dialysis Care: Trends Through August 2011 mā Ronald L. Pisoni, Douglas S. Fuller, Brian Bieber, Brenda W. Gillespie, Bruce Robinson

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    The Testicular Effects of Tumor Necrosis Factor

    The Testicular Effects of Tumor Necrosis Factor mā K. Mealy, Bruce Robinson, Clarke F. Millette, Joseph A. Majzoub, Douglas W. Wilmore

    I whakaputaina 1990
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions

    Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions mā Furio Pacini, Yasuhiro Ito, Markus Luster, Fabián Pitoia, Bruce Robinson, Lori J. Wirth

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Revisiting Survival Differences by Race and Ethnicity among Hemodialysis Patients

    Revisiting Survival Differences by Race and Ethnicity among Hemodialysis Patients mā Bruce Robinson, Marshall M. Joffe, Ronald L. Pisoni, Friedrich K. Port, Harold I. Feldman

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Management of Anemia in Nondialysis Chronic Kidney Disease: Current Recommendations, Real-World Practice, and Patient Perspectives

    Management of Anemia in Nondialysis Chronic Kidney Disease: Current Recommendations, Real-World Practice, and Patient Perspectives mā Murilo Guedes, Bruce Robinson, Gregorio T. Obrador, Allison Tong, Ronald L. Pisoni, Roberto Pecoits–Filho

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices

    Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices mā Bruce Robinson, Tadao Akizawa, Kitty J. Jager, Peter G. Kerr, Rajiv Saran, Ronald L. Pisoni

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Anemia and mortality in hemodialysis patients: Accounting for morbidity and treatment variables updated over time

    Anemia and mortality in hemodialysis patients: Accounting for morbidity and treatment variables updated over time mā Bruce Robinson, Marshall M. Joffe, Jeffrey S. Berns, Ronald L. Pisoni, Friedrich K. Port, Harold I. Feldman

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice

    A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice mā Wayne J. Aston, Danika E. Hope, Anna K. Nowak, Bruce Robinson, Richard Lake, W. Joost Lesterhuis

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: